CHINA PHARMA HOLDINGS, INC. — Director's Dealing 2021

Jan 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK: 0001106644
Period of Report: 2020-12-23

Reporting Person: Li Zhilin (Director, CEO and interim CFO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-23	Common Stock	A	2000000	$0.00	Acquired	12050000	Direct

Footnotes

F1: On December 23, 2020, the reporting person was granted 2,000,000 shares of Issuer's common stock under the Issuer's 2010 Long-Term Incentive Plan, vesting immediately with no restrictions, as partial offset of her accrued but unpaid cash compensation by serving as the Issuer's Chairman of the Board, Chief Executive Officer and interim Chief Financial Officer.